Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma

NCT01528618 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

362

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Neoplasms

Interventions

DRUG: gemcitabine and cisplatin
DRUG: 5-Fluorouracil and cisplatin

Sponsor

Sun Yat-sen University